Cheryl A. Brighton
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Drug Transport and Resistance Mechanisms, Receptor Mechanisms and Signaling, Ion Transport and Channel Regulation
Most-Cited Works
- → Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension(2013)528 cited
- → Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells(2015)370 cited
- → Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors(2015)330 cited
- → High fat diet impairs the function of glucagon-like peptide-1 producing L-cells(2015)133 cited
- → Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells(2021)101 cited
- → The severity of hereditary porphyria is modulated by the porphyrin exporter and Lan antigen ABCB6(2016)44 cited
- → Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells(2017)30 cited
- → DACH1 , a Zona Glomerulosa Selective Gene in the Human Adrenal, Activates Transforming Growth Factor-β Signaling and Suppresses Aldosterone Secretion(2015)26 cited
- → Relaxin/insulin-like family peptide receptor 4 (Rxfp4) expressing hypothalamic neurons modulate food intake and preference in mice(2022)23 cited